Tolerance of soya lecithin in children with non-immunoglobulin E-mediated soya allergy: a randomised, double-blind, cross-over trial

被引:5
|
作者
Gholmie, Y. [1 ]
Lozinsky, A. C. [2 ]
Godwin, H. [3 ]
Reeve, K. [4 ]
Dzubiak, R. [3 ]
Shah, N. [3 ]
Meyer, R. [5 ,6 ]
机构
[1] Columbia Univ Teachers Coll, Dept Hlth & Behav Sci, 525 West 120th St, New York, NY 10027 USA
[2] Great Ormond St Hosp Children NHS Fdn Trust, Dept Gastroenterol, London, England
[3] Great Ormond St Hosp Sick Children, London, England
[4] Royal London Hosp, Paediat A&E, London, England
[5] Imperial Coll London, London, England
[6] Imperial Coll London, Dept Paediat, London, England
关键词
elimination; gastrointestinal allergy; non-IgE; reaction; soya lecithin; QUALITY-OF-LIFE; FOOD; ALLERGENICITY; CHALLENGE; PROTEINS; TIME; OILS;
D O I
10.1111/jhn.12708
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background Soya lecithin is present in a wide variety of foods regularly consumed by children, in the form of an emulsifier or stabiliser. Children with non-immunoglobulin (Ig)E-mediated allergies who commonly have to avoid milk and soya will have a significantly restrictive diet with reduced alternative foods if soya lecithin also has to be eliminated. The present study aimed to establish whether children with non-IgE-mediated gastrointestinal soya allergy react to soya lecithin in food products. Methods A double-blind, cross-over study was performed in soya-allergic children aged between 8 months and 5 years. Eligible children had their soya allergy status confirmed with a home challenge. Children were randomly assigned to either placebo or challenge dose of soya lecithin (1.5 g per day) in a custom-made biscuit. This was followed by a 1-week washout period and cross-over to another 1 week of challenge or placebo dose. Symptoms were recorded prior to commencing the study and at the end of each week's challenge. Results Twenty-two children, 16 boys, with a median age of 44 months (range 21-58 months) were recruited, although only 20 completed the full study. The median number of foods avoided in addition to soya was 3. Over the challenge period, the parents reported reactions in six cases: five cases (23%) to the placebo and one case (5%) to the challenge dose. There was no statistical difference (P = 0.025) between the groups. Conclusions One child with a non-IgE-mediated gastrointestinal allergy had a slight reaction to soya lecithin. Although single cases may react to soya lecithin, we suggest that soya lecithin should be included in children with this delayed allergy, unless they have a confirmed reaction to traces of soya within this emulsifier.
引用
收藏
页码:232 / 240
页数:9
相关论文
共 50 条
  • [1] Potential non-immunoglobulin E-mediated food allergies: Comparison of open challenge and double-blind placebo-controlled food challenge
    Wang, De Yun
    Gordon, Bruce R.
    Chan, Yiong Huak
    Yeoh, Kian Hian
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2007, 137 (05) : 803 - 809
  • [2] Differential Cytokine Expression in the Duodenum and Rectum of Children with Non-Immunoglobulin E-Mediated Cow's Milk Protein Allergy
    Toro-Monjaraz, Erick M.
    Fonseca-Camarillo, Gabriela
    Zarate-Mondragon, Flora
    Montijo-Barrios, Ericka
    Cadena-Leon, Jose
    Avelar-Rodriguez, David
    Ramirez-Mayans, Jaime
    Cervantes-Bustamante, Roberto
    Yamamoto-Furusho, Jesus K.
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (11) : 3769 - 3775
  • [3] Differential Cytokine Expression in the Duodenum and Rectum of Children with Non-Immunoglobulin E-Mediated Cow’s Milk Protein Allergy
    Erick M. Toro-Monjaraz
    Gabriela Fonseca-Camarillo
    Flora Zárate-Mondragón
    Ericka Montijo-Barrios
    José Cadena-León
    David Avelar-Rodríguez
    Jaime Ramírez-Mayans
    Roberto Cervantes-Bustamante
    Jesús K. Yamamoto-Furusho
    [J]. Digestive Diseases and Sciences, 2021, 66 : 3769 - 3775
  • [4] A double-blind, cross-over trial of intravenous immunoglobulin G in multiple sclerosis: Preliminary results
    Sorensen, PS
    Wanscher, B
    Schreiber, K
    Blinkenberg, M
    Jensen, CV
    Ravnborg, M
    [J]. MULTIPLE SCLEROSIS, 1997, 3 (02): : 145 - 148
  • [5] A double-blind, randomised, controlled cross-over trial of glutamine supplementation in home parenteral nutrition
    Culkin, A.
    Gabe, S.
    Bjarnasson, I.
    Grimble, G.
    Forbes, A.
    [J]. PROCEEDINGS OF THE NUTRITION SOCIETY, 2005, 64 : 5A - 5A
  • [6] Modafinil for attentional and psychomotor dysfunction in advanced cancer: a double-blind, randomised, cross-over trial
    Lundorff, L. E.
    Jonsson, B. H.
    Sjogren, P.
    [J]. PALLIATIVE MEDICINE, 2009, 23 (08) : 731 - 738
  • [7] HALOPERIDOL AND CHLORPROMAZINE - DOUBLE-BLIND CROSS-OVER TRIAL AND CLINICAL STUDY IN CHILDREN AND ADOLESCENTS
    LEWIS, PJE
    JAMES, NM
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 1973, 7 (01): : 59 - 65
  • [8] Gastrointestinal tolerance of D-allulose in children: an acute, randomised, double-blind, placebo-controlled, cross-over study
    Risso, Davide
    Dunngalvin, Gillian
    Saxena, Sameer
    Doolan, Andrea
    Spence, Lisa
    Karnik, Kavita
    [J]. FOOD & FUNCTION, 2024, 15 (01) : 411 - 418
  • [9] A randomised, double-blind, placebo controlled, cross-over trial of adjunctive L-arginine in schizophrenia
    Kocyigit, Y.
    Ayhan, Y.
    Yoca, G.
    Karahan, S.
    Yazici, M. K.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S484 - S484
  • [10] TREATMENT OF OBESE NON-DIABETIC PATIENTS WITH PHENFORMIN . A DOUBLE-BLIND CROSS-OVER TRIAL
    HART, A
    COHEN, H
    [J]. BRITISH MEDICAL JOURNAL, 1970, 1 (5687): : 22 - &